Duet Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) and Scopus BioPharma (NASDAQ:SCPS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Profitability This table compares Enlivex Therapeutics and Scopus BioPharma’s […]

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present onTLR9 Activation and STAT3 Inhibition: A Bifunctional Approach to...